SCHEMBL4608713

SCHEMBL4608713

C#CCC1CNCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29753194 0.98 SLC6A2 (0.36)
SCHEMBL873427 0.79
SCHEMBL21069936 0.79
SCHEMBL21070848 0.79
SCHEMBL6689960 0.79
SCHEMBL1777157 0.79
SCHEMBL8742282 0.79
Hydrochloric Acid SCHEMBL3945988 0.78 SLC6A4 (0.36)
SCHEMBL2483427 0.76 SLC6A2 (0.36)
SCHEMBL1746181 0.75 SLC6A2 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107973787-B Coumarin derivative DMAC (Dimethylacetamide) and preparation method and application thereof 山西大学 2021-02-02 CN claimed
CN-107973787-A A kind of coumarin derivative DMAC and its preparation method and application 山西大学 2018-05-01 CN claimed
CN-105153214-B A kind of silicon substrate rhodamine nitric oxide fluorescent probe and its preparation method and application 中国人民解放军第二军医大学 2018-02-02 CN claimed
EP-1226126-B1 PYRIMIDINE DERIVATIVES ASTRAZENECA AB (SE) 2005-01-05 EP claimed
CN-107973787-B Coumarin derivative DMAC (Dimethylacetamide) and preparation method and application thereof 山西大学 2021-02-02 CN disclosed
CN-104761544-B The selective depressant of the important mutant of clinic of EGFR tyrosine kinase 北京轩义医药科技有限公司 2019-03-15 CN disclosed
CN-107973787-A A kind of coumarin derivative DMAC and its preparation method and application 山西大学 2018-05-01 CN disclosed
CN-105153214-B A kind of silicon substrate rhodamine nitric oxide fluorescent probe and its preparation method and application 中国人民解放军第二军医大学 2018-02-02 CN disclosed
WO-2016210239-A1 METHODS OF IDENTIFYING NOVEL ANTIBIOTICS USING IN SITU CLICK CHEMISTRY TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2016-12-29 WO disclosed
CN-101743242-A Heterocyclic compounds useful as RAF kinase inhibitors BIOGEN IDEC INC 2010-06-16 CN disclosed
EP-1979311-A2 PHENOXY ACETIC ACIDS AS PPAR DELTA ACTIVATORS TRANSTECH PHARMA (US) 2008-10-15 EP disclosed
EP-1904504-A2 INHIBITORS OF VEGF RECEPTOR AND HGF RECEPTOR SIGNALING Methylgene, Inc. (CA) 2008-04-02 EP disclosed
WO-2006010264-A1 INHIBITORS OF VEGF RECEPTOR AND HGF RECEPTOR SIGNALING METHYLGENE, INC. (CA) 2006-02-02 WO disclosed
EP-1585749-A1 DIAZEPINOINDOLE DERIVATIVES AS KINASE INHIBITORS PFIZER INC. (US) 2005-10-19 EP disclosed
WO-2004063198-A1 DIAZEPINOINDOLE DERIVATIVES AS KINASE INHIBITORS PFIZER INC. (US) 2004-07-29 WO disclosed
EP-1075467-A1 PYRAZOLE DERIVATIVES AS P-38 MAP KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2001-02-14 EP disclosed
WO-1999057101-A1 PYRAZOLE DERIVATIVES AS P-38 MAP KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 1999-11-11 WO disclosed
US-5017724-A Antihypoxic, CNS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-05-21 US disclosed
EP-0267024-B1 HYDROFLUORENE DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-05-02 EP disclosed
EP-0267024-A2 Hydrofluorene derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1988-05-11 EP disclosed